9th Annual Hematology and Medical Oncology Board Review: Contemporary Practice
$135.00
9th Annual Hematology and Medical Oncology Board Review: Contemporary Practice Video Lectures
In stock
Description
Description
This four day virtual course will provide an up-to-date and
comprehensive review of the diagnosis, staging, and
management of neoplastic disease, including
solid tumor and hematologic oncology
Lectures will focus on disease specific topics in gastrointestinal,
gynecologic, thoracic, head and neck, genitourinary, soft tissue and skin,
and central nervous system oncology, as well as hematologic oncology.
By attending this board review, attendees will:
• Learn state-of-the-science in diagnosis, staging, and therapeutic
management of solid tumor cancers
• Learn state-of-the-science in diagnosis, staging, and therapeutic
management of hematologic cancers
• Understand recent treatment advances in solid tumor and
hematologic oncology and their impact on modern clinical practice
This board review course is intended for medical oncology professionals,
including physicians, nurses, pharmacists, fellows, and residents.
MSK Course Directors
David H. Ilson, MD, PhD
Attending Physician, Gastrointestinal Oncology Service
Division of Solid Tumor Oncology
Department of Medicine
Member, Memorial Sloan Kettering Cancer Center
Professor of Medicine, Weill Cornell Medical College
This four day virtual course will provide an up-to-date and
comprehensive review of the diagnosis, staging, and
management of neoplastic disease, including
solid tumor and hematologic oncology.
Paul A. Hamlin, MD
Medical Director, David H. Koch Center for Cancer Care
Associate Attending, Lymphoma Service
Division of Hematologic Malignancies
Department of Medicine
Associate Professor of Medicine, Weill Cornell Medical College
Attendees will receive access to an online syllabus,
which includes PDFs of the slides and recorded
videos of the presentations.
CONTENT
6:45 am Virtual Course Check-in
7:00 am Welcome and Introduction Paul A. Hamlin, MD
7:05 am Pharmacology Mrinal M. Gounder, MD
9:20 am Break
9:30 am CAR T cells Renier J. Brentjens, MD, PhD
10:30 am Low Grade NHL Andrew D. Zelenetz, MD, PhD
11:00 am CLL/SLL Anthony Mato, MD
11:30 am DLBCL/MCL/BL Paul Hamlin, MD
12:30 pm Lunch Break
1:15 pm HL/T Cell Alison Moskowitz, MD
2:15 pm Auto/Allo Craig Sauter, MD
3:15 pm AML/ALL Martin S. Tallman, MD
4:15 pm Break
4:45 pm MDS/MPN Michael J. Mauro, MD
5:45 pm Myeloma/Amyloid Malin Hultcrantz, MD, PhD
6:15 pm Closing Remarks and Adjourn Paul A. Hamlin, MD
7:45 am Virtual Course Check-in
8:00 am Welcome and Introduction Paul A. Hamlin, MD
8:05 am Approach to The Bleeding Patient Rekha Parameswaran, MD
9:00 am The Role of the New Direct Oral
Anticoagulants in Practice
Simon Mantha, MD, MPH
10:00 am Thrombocytopenia, ITP and Beyond Cy Wilkins, MD
11:00 am Sickle Cell Disease, Thalassemia Jodi Mones, MD
12:00 pm Closing Remarks and Adjourn Paul A. Hamlin, MD
Reviews (4)
Only logged in customers who have purchased this product may leave a review.
4 reviews for 9th Annual Hematology and Medical Oncology Board Review: Contemporary Practice
There are no reviews yet.